ReviewTargeted oncology2022

When Less May Be Enough: Dose Selection Strategies for Immune Checkpoint Inhibitors Focusing on AntiPD-(L)1 Agents.

Daniel V Araujo et al.PubMed ↗Publisher ↗

No numbers read from the abstract.